Mortality After Multivessel Revascularization in Patients With Diabetes and Acute Coronary Syndromes.

ABSTRACT:

Background

The optimal revascularization strategy in patients with diabetes and multivessel disease in the setting of a non-ST-segment elevation myocardial infarction (NSTEMI) is unknown.

Objectives

The purpose of this study was to compare all-cause mortality between coronary artery bypass grafting (CABG) and multivessel percutaneous coronary intervention (PCI) among patients with diabetes and NSTEMI.

Methods

All patients with diabetes and multivessel disease admitted for NSTEMI in Ontario, Canada, between April 2009 and March 2020 were included. Those with previous CABG, PCI in the previous 90 days, or shock were excluded. The primary outcome was all-cause mortality. Propensity score matching was used to account for confounding. Patients who had a cardiac surgeon con

SUBMITTER: Godoy LC 

PROVIDER: S-EPMC11450960 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature